During the past decade, Hospital Clinico Universidad Catolica conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 5 clinical trials were completed, i.e. on average, 26.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Clinico Universidad Catolica" #1 sponsor was "Pontificia Universidad Catolica de Chile" with 21 trials, followed by "PTC Therapeutics" with 2 trials sponsored, "Endologix" with 1 trials sponsored, "Fresenius Kabi" with 1 trials sponsored and "GI Dynamics" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Clinico Universidad Catolica" #1 collaborator was "Fondo Nacional de Desarrollo Científico y Tecnológico, Chile" with 3 trials as a collaborator, "Comisión Nacional de Investigación Científica y Tecnológica" with 1 trials as a collaborator and "Fundacion Arturo Lopez Perez" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Clinico Universidad Catolica" are "Obesity" (3 trials), "Acute Respiratory Distress Syndrome" (2 trials), "Genetic Diseases, Inborn" (2 trials), "Genetic Diseases, X-Linked" (2 trials) and "Muscular Diseases" (2 trials). Many other conditions were trialed in "Hospital Clinico Universidad Catolica" in a lesser frequency.

Most popular intervention types in "Hospital Clinico Universidad Catolica" are "Drug" (14 trials), "Device" (6 trials), "Other" (4 trials), "Biological" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ataluren" (2 trials), "Dexmedetomidine" (2 trials), "Amikacin Sulfate Injection" (1 trials) and "COVID-19 convalescent plasma" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Clinico Universidad Catolica" are 26 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Clinico Universidad Catolica". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Hospital Clinico Universidad Catolica, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Clinico Universidad Catolica, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 5 trials that are defined as “Not Applicable".

Hospital Clinico Universidad Catolica has several departments that took part in Clinical trials: "Centro de Cancer Pontificie Universidad Catolica de Chile" - 4 trials